[Experimental and clinical data on the intravenous therapy of tuberculosis meningitis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001770:Blood Bactericidal Activity; D001921:Brain / Q000382:microbiology; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011817:Rabbits; D013307:Streptomycin / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007538:Isoniazid; D013307:Streptomycin
Eksperimental'nye i klinicheskie dannye po vnutrivennoĭ terapii tuberkuleznogo meningita